Warsaw 2013 Programme Registration Exhibition Hotels Virtual Exhibition Warsaw Satellite Meetings Visa Information

Myopic anterior chamber phakic IOL complications

Poster Details

First Author: I.Grabska-Liberek POLAND

Co Author(s):    A. Jamrozy Witkowska   K. Zelek           

Abstract Details



Purpose:

The aim of this study was to analyze the complications of anterior chamber phakic intraocular lens (IOL) implantation in highly myopic eyes

Setting:

: The Medical Centre of Postgraduate Education, Department of Ophthalmology in Warsaw, Microsurgery Eye Center Laser in Warsaw, Poland

Methods:

Retrospective study. We have studied 20 eyes of 15 patients treated with anterior chamber phakic IOL implantation (I-Care). During follow-up some complications occurred and all phakic IOL were explanted following by phacoemulsification and posterior chamber IOL implantation. The average myopia diopter before phakic IOL implantation was 14.1 D (-9.0 to -21.0 D). Pre- and postoperative patient evaluation included best corrected visual acuity (BCVA), endothelial cell count, intraocular pressure, complication rate.

Results:

The mean time between phakic IOL implantation and secondary intervention was 61.9 months (2.8 -8.7 years).The BCVA remain the same or improved in 100 % of eyes after both phakic IOL implantation and explantation with phacoemulsification. The average corneal endothelial count before first surgery was 3230.9/mm2 (2584-4182), before second surgery was 1207/mm2 (880-2041) . Three eyes with phakic IOL developed bullous kerathopathy. In another three eyes we noticed high IOP (30, 45, 50 mmHg respectively) and introduced antiglaucomatous drops. These 3 eyes required trabeculectomy or cyclophotocoagulation or Ahmed valve atfer second surgical intervention. Two eyes developed rhematogenous retina detachment.

Conclusions:

The most frequent reason for phakic IOL explantation was endothelial cell loss. Phakic IOL explantation with phacoemulsyfication was safe and effective procedure. Rigorous follow-up of the implanted eyes is required.

Financial Disclosure:

None

Back to previous